(Q39565349)

13 September 2017

TXNIP potentiates Redd1-induced mTOR suppression through stabilization of Redd1. (English)

1 reference

13 September 2017

H-O Jin

1

1 reference

13 September 2017

S-K Seo

2

1 reference

13 September 2017

Y-S Kim

3

1 reference

13 September 2017

S-H Woo

4

1 reference

13 September 2017

K-H Lee

5

1 reference

13 September 2017

J-Y Yi

6

1 reference

13 September 2017

S-J Lee

7

1 reference

13 September 2017

T-B Choe

8

1 reference

13 September 2017

J-H Lee

9

1 reference

13 September 2017

S An

10

1 reference

13 September 2017

S-I Hong

11

1 reference

13 September 2017

I-C Park

12

1 reference

13 September 2017

language of work or name

English

0 references

publication date

4 April 2011

1 reference

13 September 2017

1 reference

13 September 2017

30

1 reference

13 September 2017

35

1 reference

13 September 2017

3792-3801

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2011.102

13 September 2017

0 references

cites work

Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Vitamin D3 upregulated protein 1 (VDUP1) is a regulator for redox signaling and stress-mediated diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Mammalian TOR: a homeostatic ATP sensor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Search for genes that suppress cancer metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

VDUP1 upregulated by TGF-beta1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

AMP-activated protein kinase: the energy charge hypothesis revisited

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Negative feedback control of HIF-1 through REDD1-regulated ROS suppresses tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

TSC2 mediates cellular energy response to control cell growth and survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Nuclear protein 1 induced by ATF4 in response to various stressors acts as a positive regulator on the transcriptional activation of ATF4.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Activating transcription factor 4 and CCAAT/enhancer-binding protein-beta negatively regulate the mammalian target of rapamycin via Redd1 expression in response to oxidative and endoplasmic reticulum stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

2-Deoxyglucose: an anticancer and antiviral therapeutic, but not any more a low glucose mimetic

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

REDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A-DDB1 ubiquitin ligase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Heat shock factor regulates VDUP1 gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Extracellular thioredoxin and thioredoxin-binding protein 2 in control of cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Importin alpha1 (Rch1) mediates nuclear translocation of thioredoxin-binding protein-2/vitamin D(3)-up-regulated protein 1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Impaired fatty acid utilization in thioredoxin binding protein-2 (TBP-2)-deficient mice: a unique animal model of Reye syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

TOR, a central controller of cell growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Hypoxia-induced energy stress inhibits the mTOR pathway by activating an AMPK/REDD1 signaling axis in head and neck squamous cell carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Vitamin D3-upregulated protein-1 (VDUP-1) regulates redox-dependent vascular smooth muscle cell proliferation through interaction with thioredoxin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Hepatocellular carcinoma in Txnip-deficient mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Targeting mTOR globally in cancer: thinking beyond rapamycin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Regulation of mTOR and cell growth in response to energy stress by REDD1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

The regulation of AMP-activated protein kinase by phosphorylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Glucose sensing by MondoA:Mlx complexes: a role for hexokinases and direct regulation of thioredoxin-interacting protein expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

Thioredoxin-interacting protein (txnip) is a glucocorticoid-regulated primary response gene involved in mediating glucocorticoid-induced apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

ATF4 is necessary and sufficient for ER stress-induced upregulation of REDD1 expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.102

31 March 2020

Identifiers

DOI

10.1038/ONC.2011.102

1 reference

Dimensions Publication ID

13 September 2017

0 references

1 reference